XML 36 R20.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Derivatives
12 Months Ended
Mar. 31, 2024
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Derivatives DERIVATIVES
From time to time, we enter into interest rate swaps to fix a portion of our interest expense, and foreign exchange forward contracts to offset the earnings impacts of exchange rate fluctuations on certain monetary assets and liabilities. We do not enter into derivative instruments for any purpose other than to manage interest rate or foreign currency exposure. That is, we do not engage in interest rate or currency exchange rate speculation using derivative instruments.
We may hedge our net recognized foreign currency assets and liabilities with forward foreign exchange contracts to reduce the risk that our earnings and cash flows will be adversely affected by changes in foreign currency exchange rates. These derivative instruments hedge assets and liabilities that are denominated in foreign currencies and are carried at fair value with changes in the fair value recorded as other income. These derivative instruments do not subject us to material balance sheet risk due to exchange rate movements because gains and losses on these derivatives are intended to offset gains and losses on the assets and liabilities being hedged.

As of March 31, 2024, we did not have any outstanding contract notional amounts.

The fair value of our derivative instruments was included in our Consolidated Balance Sheets as follows (in thousands):

Balance Sheet ClassificationAs of March 31,
 20242023
Derivative instruments not designated as cash flow hedges:
Foreign currency forward contractsAccrued liabilities$— $141 

The effect of derivative instruments on our Consolidated Statements of Operations was as follows (in thousands):

Statement of Operations ClassificationYear Ended March 31,
 20242023
Derivative instruments not designated as cash flow hedges:
 Gain (loss) recognized in earnings
Other, net$178 $(24)
 Income tax expense
Income tax expense
44 

For additional information related to our derivatives, see Notes 9 and 22.